158 related articles for article (PubMed ID: 22319069)
1. Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosis.
Maluenda G; Ben-Dor I; Gaglia MA; Wakabayashi K; Mahmoudi M; Sardi G; Laynez-Carnicero A; Torguson R; Xue Z; Margulies AD; Suddath WO; Kent KM; Bernardo NL; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2012 Feb; 5(1):12-9. PubMed ID: 22319069
[TBL] [Abstract][Full Text] [Related]
2. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
[TBL] [Abstract][Full Text] [Related]
3. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.
Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R
J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.
Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ
J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303
[TBL] [Abstract][Full Text] [Related]
6. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
[TBL] [Abstract][Full Text] [Related]
7. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
9. Vascular brachytherapy for patients with drug-eluting stent restenosis.
Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R
J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the Korean DES ISR multicenter registry study [KISS]).
Ko YG; Kim JS; Kim BK; Choi D; Hong MK; Jeon DW; Yang JY; Ahn YK; Jeong MH; Yu CW; Yun KH; Lim DS; Jang Y;
Am J Cardiol; 2012 Mar; 109(5):607-13. PubMed ID: 22172241
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.
Abe M; Kimura T; Morimoto T; Taniguchi T; Yamanaka F; Nakao K; Yagi N; Kokubu N; Kasahara Y; Kataoka Y; Otsuka Y; Kawamura A; Miyazaki S; Nakao K; Horiuchi K; Ito A; Hoshizaki H; Kawaguchi R; Setoguchi M; Inada T; Kishi K; Sakamoto H; Morioka N; Imai M; Shiomi H; Nonogi H; Mitsudo K;
Circulation; 2010 Jul; 122(1):42-51. PubMed ID: 20566954
[TBL] [Abstract][Full Text] [Related]
12. Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme.
Lee MS; Yang T; Lasala JM; Cox DA; Bowman TS; Starzyk RM; Dawkins KD
EuroIntervention; 2011 Jul; 7(3):314-22. PubMed ID: 21729833
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
Qasim A; Cosgrave J; Latib A; Colombo A
Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
[TBL] [Abstract][Full Text] [Related]
14. New drug-eluting stent implantation for recalcitrant in-stent restenosis treated with drug-eluting stents. the Stent-in-Stent Cube (SIS³) registry.
Meliga E; De Benedictis M; Gagnor A; Scrocca I; Lombardi P; Aranzulla T; Varbella F; Conte MR
J Invasive Cardiol; 2011 Sep; 23(9):365-8. PubMed ID: 21891807
[TBL] [Abstract][Full Text] [Related]
15. Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]).
Alfonso F; Pérez-Vizcayno MJ; Dutary J; Zueco J; Cequier A; García-Touchard A; Martí V; Lozano I; Angel J; Hernández JM; López-Mínguez JR; Melgares R; Moreno R; Seidelberger B; Fernández C; Hernandez R;
JACC Cardiovasc Interv; 2012 Jul; 5(7):728-37. PubMed ID: 22814777
[TBL] [Abstract][Full Text] [Related]
16. One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry.
Vaquerizo B; Serra A; Miranda-Guardiola F; Martínez V; Antoni Gómez-Hospital J; Iñiguez A; Fernández E; Ramón Rumoroso J; Bosa F; Otaegui I
J Interv Cardiol; 2011 Dec; 24(6):518-28. PubMed ID: 21917013
[TBL] [Abstract][Full Text] [Related]
17. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
[TBL] [Abstract][Full Text] [Related]
18. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.
Torguson R; Sabate M; Deible R; Smith K; Chu WW; Kent KM; Pichard AD; Suddath WO; Satler LF; Waksman R
Am J Cardiol; 2006 Nov; 98(10):1340-4. PubMed ID: 17134625
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents.
Chen SL; Xu B; Mintz G; Ye F; Zhang JJ; Kan J; Sun XW; Zhang AP; Chen JG; Qian J; Kwan TW
Chin Med J (Engl); 2010 Apr; 123(7):794-9. PubMed ID: 20497666
[TBL] [Abstract][Full Text] [Related]
20. Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure.
Kubo S; Kadota K; Otsuru S; Hasegawa D; Habara S; Tada T; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
EuroIntervention; 2015 Jan; 10(9):e1-8. PubMed ID: 25599699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
